Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AI for Anemia Management in ESRD
NCT03214627Terminated
- Sponsor
- CSL Vifor
- Start
- Dec 2018
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in anemia and end stage renal disease (ESRD), sponsored by CSL Vifor. Primary endpoints: Change in the proportion of patients with haemoglobin within the target range as compared to the historical control period (non-inferiority testing) at 6 months and Change in the proportion of patients with haemoglobin within the target range as compared to historical control period (superiority testing) at 6 months. Started Dec 2018; status: terminated.
02
Conditions
anemiaend stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT03214627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03214627.